Filing Details

Accession Number:
0001209191-19-062322
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-31 17:55:54
Reporting Period:
2019-12-27
Accepted Time:
2019-12-31 17:55:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1755237 Cyclerion Therapeutics Inc. CYCN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1478244 G Mark Currie C/O Cyclerion Therapeutics, Inc.
301 Binney Street
Cambridge MA 02142
President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-12-27 25,000 $2.55 296,755 No 4 S Direct
Common Stock Disposition 2019-12-30 25,000 $2.48 271,755 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The proceeds from the sale are intended to cover income taxes arising out of prior stock option exercises, including those in which the reporting person held the underlying shares.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.54 to $2.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.38 to $2.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.